All about sales now and reoccurring contract revenues.... in very simplistic terms they need to make more than they spend. Let’s hope the board, sales team and product can bring home the goods.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025